Blundell Biotech. Blundell Biotech is a U.S.-based biotechnology company with operations and earnings in a number of foreign countries. The company’s profits by subsidiary, in local currency (in millions), are shown in the table

(a) below for 2013 and 2014.

The average exchange rate for each year, by currency pairs, was as shown in table

(b) below. Use this data to answer the following questions.

a. What were Blundvell Biotech’s consolidated profits in U.S. dollars in 2013 and 2014?

b. If the same exchange rates were used for both years, what was the change in corporate earnings on a “constant currency” basis?

c. Using the results of the constant currency analysis in part

b, is it possible to separate Blundell’s growth in earnings between local currency earnings and foreign exchange rate impacts on a consolidated basis?

Transcribed Image Text:

(a) Japanese British Net Income Subsidiary Subsidiary European Subsidiary Chinese Subsidiary Russian Subsidiary United States Subsidiary 2013 JPY1,500 GBP100.00 EUR204.00 CNY168.00 RUB124.00 USD360.00 2014 JPY1,460 GBP106.40 EUR208.00 CNY194.00 RUB116.00 USD382.00 (b) Exchange Rate 2013 2014 JPY = 1 USD 97.57 105.88 USD = 1 GBP USD = 1 EUR CNY = 1 USD RUB 1 USD USD 1.5646 1.3286 6.1484 31.86 1.0000 1.6473 1.3288 6.1612 38.62 1.0000